Xcout Intel
Reverb Therapeutics
Reverb Therapeutics is a biotechnology research company headquartered in Vancouver, British Columbia. The company focuses on cancer therapeutics by developing its proprietary Amplify-R platform designed to intelligently adjust and tune the body's natural immune system.
Subscribe to see Reverb Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Reverb Therapeutics at a glance
Reverb Therapeutics is a biotechnology company headquartered in Canada. It has raised at least $17M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Seed, raised $17M in February 2025. Xcout tracks 12 named people at Reverb Therapeutics, including Jean M. Jen (Chief Financial Officer).
Reverb Therapeutics leadership
- Jean M. JenChief Financial Officer
- Ahmed AlkhateebChief Business Officer
- Diana HausmanChief Medical Officer
- John M. BurkeChief Pharmacology Officer
- David de GraafFounder and Chief Executive Officer
- SURJIT DIXITFounder and Chief Scientific Officer
6 more named people on record for Reverb Therapeutics, with roles, board committees and tenure — see the full roster →
Reverb Therapeutics funding rounds
At least $17M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $17M | 9 named | |
| Seed | Undisclosed | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Reverb Therapeutics competitors
A few of Reverb Therapeutics's closest competitors — see the full list of competitors and alternatives →
Evolved Therapeutics is a life sciences company headquartered in Vancouver, British Columbia, operating in the antibody discovery sector. The organization focuses on establishing innovative function-first antibody discovery platforms.
ImStar Therapeutics Inc. is a biotechnology company headquartered in Vancouver, British Columbia, focused on breakthrough science and drug discovery.
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Amphivena Therapeutics, Inc. is a privately held, clinical-stage biotechnology company based in South San Francisco, California. The company specializes in immuno-oncology, developing a platform of dual-function biologics and selective T cell engagers for the treatment of hematological conditions.
Silverback Therapeutics, Inc. is a biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop therapeutic products.
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Get Reverb Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Reverb Therapeutics in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access